Method of using cut&run or cut&tag to validate crispr-cas targeting
OwnerStefan Pellenzinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerStefan Pellenzinventor
Estimating the term…
The invention relates to using CUT&RUN to validate CRISPR-Cas targeting. To improve the efficiency of CRISPR-based gene editing and delivery for in vivo applications, a method which may comprise: (a) expressing a catalytically inactive Cas protein (dCas) in target cells, (b) optional hypotonic lysis of the cells of step (a) to release nuclei, (c) immobilizing cells of step (a) or nuclei of step (b) with magnetic beads, (d) incubating the product of step (c) with an anti-CRISPR-dCas antibody, (e) incubating the product of step (d) with ProteinA-MNase (pAG-MNase), (f) adding of a Ca2+ ions-containing buffer to start MNase digestion and release of pAG-MNase-antibody-chromatin complexes, (g) adding a chelator-containing buffer to stop the reaction of step (f), (h) pelletizing the obtained oligonucleosome and obtaining pAG-MNasebound digested chromatin fragments from the supernatant, (i) extracting of DNA and RNA from the chromatin fragments of step (h), and (j) sequencing of DNA and RNA.
A method to validate CRISPR-Cas targeting comprising the following steps:
A method to validate CRISPR-Cas targeting comprising the following steps:
Dependencies are inferred from the claim text.